Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BOOK OF ABSTRACTS | HEALTH EQUITY
BOOKS OF ABSTRACTS | HEALTH EQUITY
Brief Research Article | HIV and AIDS
COMMENTARY
COMMENTARY | CHLAMYDIA
COMMENTARY | COVID-19 AND HIV/AIDS
COMMENTARY | COVID-19 VACCINE
COMMENTARY | DIGITAL HEALTH
COMMENTARY | EMERGENCY PRACTICE
COMMENTARY | HIV Testing
COMMENTARY | MALARIA
COMMENTARY | MATERNAL HEALTH
COMMENTARY | MATERNAL MORTALITY
COMMENTARY | MONKEYPOX
COMMENTARY | PERINATAL HIV TRANSMISSION
Editorial
EDITORIAL | BRAIN DRAIN
EDITORIAL | POSTPARTUM HEMORRHAGE PREVENTION
FIELD STUDIES, INFECTION CONTROL
LETTER TO EDITOR | INTERTRIGINOUS DERMATITIS
LETTER TO THE EDITOR | COVID-19 PANDEMIC
LETTER TO THE EDITOR | COVID-19 TEST
METHODOLOGY ARTICLE
METHODOLOGY ARTICLE | HIV
NARRATIVE REVIEW | MATERNAL HEALTH
NOTES FROM THE FIELD | COVID-19 PANDEMIC
NOTES FROM THE FIELD | MCH STUDENT ASSOCIATION
Original Article
ORIGINAL ARTICLE | ADOLESCENT HEALTH
ORIGINAL ARTICLE | AMERICAN INDIAN AND ALASKA NATIVE HEALTH
ORIGINAL ARTICLE | ANTENATAL CARE SERVICES
ORIGINAL ARTICLE | BIRTH INTERVAL
ORIGINAL ARTICLE | CAFFEINE AND CHILDHOOD OBESITY
ORIGINAL ARTICLE | CERVICAL PRECANCER
ORIGINAL ARTICLE | CHILD HEALTH
ORIGINAL ARTICLE | CHILD HEALTHCARE
ORIGINAL ARTICLE | CLUBFOOT
ORIGINAL ARTICLE | COMPLEMENTARY FEEDING PRACTICES
ORIGINAL ARTICLE | CONTINUUM OF CARE
ORIGINAL ARTICLE | COVID-19 DISEASE
ORIGINAL ARTICLE | COVID-19 IN PREGNANCY
ORIGINAL ARTICLE | COVID-19 OUTCOMES
ORIGINAL ARTICLE | DEPRESSION & HIV
ORIGINAL ARTICLE | DIETARY MICRONUTRIENTS AND HIV
Original Article | Female Sexual Dysfunction
ORIGINAL ARTICLE | FETAL ANOMALIES
ORIGINAL ARTICLE | HEALTHCARE SERVICES
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, PUBLIC-PRIVATE PARTNERSHIP
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, TRANEXAMIC ACID
ORIGINAL ARTICLE | HIV
ORIGINAL ARTICLE | HIV AND PREGNANCY
ORIGINAL ARTICLE | HIV AND PREGNANT WOMEN
ORIGINAL ARTICLE | HIV INFECTION
ORIGINAL ARTICLE | HIV PREVENTION
ORIGINAL ARTICLE | HIV SCREENING
Original Article | HIV Seroprevalence
ORIGINAL ARTICLE | HIV TESTING
ORIGINAL ARTICLE | HIV Viral Load
ORIGINAL ARTICLE | HIV-TB CO-INFECTIONS
ORIGINAL ARTICLE | HIV/AIDS
ORIGINAL ARTICLE | HIV/AIDS IN ECUADOR
ORIGINAL ARTICLE | HOME DELIVERY
ORIGINAL ARTICLE | HOUSING AND HOUSING INEQUALITIES
ORIGINAL ARTICLE | IMMUNIZATION
ORIGINAL ARTICLE | IMMUNIZATION COVERAGE
ORIGINAL ARTICLE | INFANT HEALTH
ORIGINAL ARTICLE | INFLAMMATORY BOWEL DISEASE
ORIGINAL ARTICLE | LEISHMANIASIS
ORIGINAL ARTICLE | LIFE EXPECTANCY
ORIGINAL ARTICLE | MALARIA & HIV
ORIGINAL ARTICLE | MATERNAL AND CHILD HEALTH
ORIGINAL ARTICLE | MATERNAL HEALTH
ORIGINAL ARTICLE | MATERNAL HEALTH SERVICES
ORIGINAL ARTICLE | MATERNAL MORTALITY
ORIGINAL ARTICLE | MATERNAL OBESITY
ORIGINAL ARTICLE | MCH HEALTHCARE SERVICES
ORIGINAL ARTICLE | MORTALITY
ORIGINAL ARTICLE | MOTHER-TO-CHILD HIV TRANSMISSION
ORIGINAL ARTICLE | MOTHER-TO-CHILD TRANSMISSION
ORIGINAL ARTICLE | NEONATAL MORTALITY
ORIGINAL ARTICLE | NEONATAL-PERINATAL MEDICINE
ORIGINAL ARTICLE | OBSTETRIC FISTULA REPAIR
Original Article | Obstetric Pain
ORIGINAL ARTICLE | ORAL HEALTH
ORIGINAL ARTICLE | OXYTOCIN VS MISOPROSTOL IN PPH
ORIGINAL ARTICLE | PEDIATRIC HIV
ORIGINAL ARTICLE | PERIODONTITIS
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE MANAGEMENT
ORIGINAL ARTICLE | PPH IN HUMANITARIAN SETTINGS
ORIGINAL ARTICLE | PPH STUDY IN KENYA
ORIGINAL ARTICLE | PPH STUDY IN UGANDA
ORIGINAL ARTICLE | PRE-ECLAMPSIA
ORIGINAL ARTICLE | PREGNANCY
ORIGINAL ARTICLE | PREGNANT WOMEN’S ORAL HEALTH
ORIGINAL ARTICLE | PRENATAL CARE
ORIGINAL ARTICLE | PUERPERAL SEPSIS
ORIGINAL ARTICLE | REPRODUCTIVE HEALTH
Original Article | Respiratory Distress Syndrome
ORIGINAL ARTICLE | TEENAGE PREGNANCY
ORIGINAL ARTICLE | VACCINATION
ORIGINAL ARTICLE | VACCINE
ORIGINAL ARTICLE | VACCINE EQUITY
ORIGINAL ARTICLE | VIRTUAL PRENATAL CARE
ORIGINAL ARTICLE | WOMEN HEALTH
ORIGINAL ARTICLE | WOMEN’S HEALTH
Original Article | Women’s Health Services
ORIGINAL ARTICLE | YOUTH MORTALITY
Original Research | Article Healthcare
ORIGINAL RESEARCH ARTICLE | MATERNAL MORTALITY
ORIGINAL RESEARCH ARTICLE | PEDIATRIC HIV
Perspective | HIV and AIDS
PERSPECTIVE | MPOX AND BREASTFEEDING
Perspective | Telehealth
PROTOCOL | PREGNANCY
PUBLIC HEALTH PRACTICE | ACADEMIC DETAILING
PUBLIC HEALTH PRACTICE | CHILD DEVELOPMENT
PUBLIC HEALTH PRACTICE | CHILD HEALTH
PUBLIC HEALTH PRACTICE | HIV
PUBLIC HEALTH PRACTICE | MAMMOGRAPHY
PUBLIC HEALTH PRACTICE | MATERNAL HEALTH
PUBLIC HEALTH PRACTICE | OPT-OUT APPROACH IN HIV TESTING
PUBLIC HEALTH PRACTICE | PREGNANCY WHEEL
PUBLIC HEALTH PRACTICE | SURVEILLANCE
RESEARCH COMMENTARY
Review Article
REVIEW ARTICLE | HIV TESTING
REVIEW ARTICLE | NEONATAL-PERINATAL MEDICINE
SHORT RESEARCH COMMUNICATION
SHORT RESEARCH COMMUNICATION | COVID AND MENTAL HEALTH
SHORT RESEARCH COMMUNICATION | COVID MCH RESEARCH AGENDA
SHORT RESEARCH COMMUNICATION | COVID-19
SHORT RESEARCH COMMUNICATION | COVID-19 AND CHILD VACCINATION
SHORT RESEARCH COMMUNICATION | COVID-19 AND MATERNAL MORTALITY
SHORT RESEARCH COMMUNICATION | COVID-19 AND REMOTE WORKERS
SHORT RESEARCH COMMUNICATION | COVID-19 PANDEMIC DISPARITIES
SHORT RESEARCH COMMUNICATION | HEALTHCARE PROVIDER TRAINING
SHORT RESEARCH COMMUNICATION | MALARIA
SHORT RESEARCH COMMUNICATION | SINGLETONS, TWINS, MULTIPLE BIRTHS
SHORT RESEARCH COMMUNICATION | SURVEILLANCE SYSTEM FOR COVID-19
SHORT RESEARCH COMMUNICATION | WOMEN’S HEALTH
SYSTEMATIC REVIEW
SYSTEMATIC REVIEW ARTICLE | UTI AND PULMONARY INJURY
WAME STATEMENT
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BOOK OF ABSTRACTS | HEALTH EQUITY
BOOKS OF ABSTRACTS | HEALTH EQUITY
Brief Research Article | HIV and AIDS
COMMENTARY
COMMENTARY | CHLAMYDIA
COMMENTARY | COVID-19 AND HIV/AIDS
COMMENTARY | COVID-19 VACCINE
COMMENTARY | DIGITAL HEALTH
COMMENTARY | EMERGENCY PRACTICE
COMMENTARY | HIV Testing
COMMENTARY | MALARIA
COMMENTARY | MATERNAL HEALTH
COMMENTARY | MATERNAL MORTALITY
COMMENTARY | MONKEYPOX
COMMENTARY | PERINATAL HIV TRANSMISSION
Editorial
EDITORIAL | BRAIN DRAIN
EDITORIAL | POSTPARTUM HEMORRHAGE PREVENTION
FIELD STUDIES, INFECTION CONTROL
LETTER TO EDITOR | INTERTRIGINOUS DERMATITIS
LETTER TO THE EDITOR | COVID-19 PANDEMIC
LETTER TO THE EDITOR | COVID-19 TEST
METHODOLOGY ARTICLE
METHODOLOGY ARTICLE | HIV
NARRATIVE REVIEW | MATERNAL HEALTH
NOTES FROM THE FIELD | COVID-19 PANDEMIC
NOTES FROM THE FIELD | MCH STUDENT ASSOCIATION
Original Article
ORIGINAL ARTICLE | ADOLESCENT HEALTH
ORIGINAL ARTICLE | AMERICAN INDIAN AND ALASKA NATIVE HEALTH
ORIGINAL ARTICLE | ANTENATAL CARE SERVICES
ORIGINAL ARTICLE | BIRTH INTERVAL
ORIGINAL ARTICLE | CAFFEINE AND CHILDHOOD OBESITY
ORIGINAL ARTICLE | CERVICAL PRECANCER
ORIGINAL ARTICLE | CHILD HEALTH
ORIGINAL ARTICLE | CHILD HEALTHCARE
ORIGINAL ARTICLE | CLUBFOOT
ORIGINAL ARTICLE | COMPLEMENTARY FEEDING PRACTICES
ORIGINAL ARTICLE | CONTINUUM OF CARE
ORIGINAL ARTICLE | COVID-19 DISEASE
ORIGINAL ARTICLE | COVID-19 IN PREGNANCY
ORIGINAL ARTICLE | COVID-19 OUTCOMES
ORIGINAL ARTICLE | DEPRESSION & HIV
ORIGINAL ARTICLE | DIETARY MICRONUTRIENTS AND HIV
Original Article | Female Sexual Dysfunction
ORIGINAL ARTICLE | FETAL ANOMALIES
ORIGINAL ARTICLE | HEALTHCARE SERVICES
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, PUBLIC-PRIVATE PARTNERSHIP
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, TRANEXAMIC ACID
ORIGINAL ARTICLE | HIV
ORIGINAL ARTICLE | HIV AND PREGNANCY
ORIGINAL ARTICLE | HIV AND PREGNANT WOMEN
ORIGINAL ARTICLE | HIV INFECTION
ORIGINAL ARTICLE | HIV PREVENTION
ORIGINAL ARTICLE | HIV SCREENING
Original Article | HIV Seroprevalence
ORIGINAL ARTICLE | HIV TESTING
ORIGINAL ARTICLE | HIV Viral Load
ORIGINAL ARTICLE | HIV-TB CO-INFECTIONS
ORIGINAL ARTICLE | HIV/AIDS
ORIGINAL ARTICLE | HIV/AIDS IN ECUADOR
ORIGINAL ARTICLE | HOME DELIVERY
ORIGINAL ARTICLE | HOUSING AND HOUSING INEQUALITIES
ORIGINAL ARTICLE | IMMUNIZATION
ORIGINAL ARTICLE | IMMUNIZATION COVERAGE
ORIGINAL ARTICLE | INFANT HEALTH
ORIGINAL ARTICLE | INFLAMMATORY BOWEL DISEASE
ORIGINAL ARTICLE | LEISHMANIASIS
ORIGINAL ARTICLE | LIFE EXPECTANCY
ORIGINAL ARTICLE | MALARIA & HIV
ORIGINAL ARTICLE | MATERNAL AND CHILD HEALTH
ORIGINAL ARTICLE | MATERNAL HEALTH
ORIGINAL ARTICLE | MATERNAL HEALTH SERVICES
ORIGINAL ARTICLE | MATERNAL MORTALITY
ORIGINAL ARTICLE | MATERNAL OBESITY
ORIGINAL ARTICLE | MCH HEALTHCARE SERVICES
ORIGINAL ARTICLE | MORTALITY
ORIGINAL ARTICLE | MOTHER-TO-CHILD HIV TRANSMISSION
ORIGINAL ARTICLE | MOTHER-TO-CHILD TRANSMISSION
ORIGINAL ARTICLE | NEONATAL MORTALITY
ORIGINAL ARTICLE | NEONATAL-PERINATAL MEDICINE
ORIGINAL ARTICLE | OBSTETRIC FISTULA REPAIR
Original Article | Obstetric Pain
ORIGINAL ARTICLE | ORAL HEALTH
ORIGINAL ARTICLE | OXYTOCIN VS MISOPROSTOL IN PPH
ORIGINAL ARTICLE | PEDIATRIC HIV
ORIGINAL ARTICLE | PERIODONTITIS
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE MANAGEMENT
ORIGINAL ARTICLE | PPH IN HUMANITARIAN SETTINGS
ORIGINAL ARTICLE | PPH STUDY IN KENYA
ORIGINAL ARTICLE | PPH STUDY IN UGANDA
ORIGINAL ARTICLE | PRE-ECLAMPSIA
ORIGINAL ARTICLE | PREGNANCY
ORIGINAL ARTICLE | PREGNANT WOMEN’S ORAL HEALTH
ORIGINAL ARTICLE | PRENATAL CARE
ORIGINAL ARTICLE | PUERPERAL SEPSIS
ORIGINAL ARTICLE | REPRODUCTIVE HEALTH
Original Article | Respiratory Distress Syndrome
ORIGINAL ARTICLE | TEENAGE PREGNANCY
ORIGINAL ARTICLE | VACCINATION
ORIGINAL ARTICLE | VACCINE
ORIGINAL ARTICLE | VACCINE EQUITY
ORIGINAL ARTICLE | VIRTUAL PRENATAL CARE
ORIGINAL ARTICLE | WOMEN HEALTH
ORIGINAL ARTICLE | WOMEN’S HEALTH
Original Article | Women’s Health Services
ORIGINAL ARTICLE | YOUTH MORTALITY
Original Research | Article Healthcare
ORIGINAL RESEARCH ARTICLE | MATERNAL MORTALITY
ORIGINAL RESEARCH ARTICLE | PEDIATRIC HIV
Perspective | HIV and AIDS
PERSPECTIVE | MPOX AND BREASTFEEDING
Perspective | Telehealth
PROTOCOL | PREGNANCY
PUBLIC HEALTH PRACTICE | ACADEMIC DETAILING
PUBLIC HEALTH PRACTICE | CHILD DEVELOPMENT
PUBLIC HEALTH PRACTICE | CHILD HEALTH
PUBLIC HEALTH PRACTICE | HIV
PUBLIC HEALTH PRACTICE | MAMMOGRAPHY
PUBLIC HEALTH PRACTICE | MATERNAL HEALTH
PUBLIC HEALTH PRACTICE | OPT-OUT APPROACH IN HIV TESTING
PUBLIC HEALTH PRACTICE | PREGNANCY WHEEL
PUBLIC HEALTH PRACTICE | SURVEILLANCE
RESEARCH COMMENTARY
Review Article
REVIEW ARTICLE | HIV TESTING
REVIEW ARTICLE | NEONATAL-PERINATAL MEDICINE
SHORT RESEARCH COMMUNICATION
SHORT RESEARCH COMMUNICATION | COVID AND MENTAL HEALTH
SHORT RESEARCH COMMUNICATION | COVID MCH RESEARCH AGENDA
SHORT RESEARCH COMMUNICATION | COVID-19
SHORT RESEARCH COMMUNICATION | COVID-19 AND CHILD VACCINATION
SHORT RESEARCH COMMUNICATION | COVID-19 AND MATERNAL MORTALITY
SHORT RESEARCH COMMUNICATION | COVID-19 AND REMOTE WORKERS
SHORT RESEARCH COMMUNICATION | COVID-19 PANDEMIC DISPARITIES
SHORT RESEARCH COMMUNICATION | HEALTHCARE PROVIDER TRAINING
SHORT RESEARCH COMMUNICATION | MALARIA
SHORT RESEARCH COMMUNICATION | SINGLETONS, TWINS, MULTIPLE BIRTHS
SHORT RESEARCH COMMUNICATION | SURVEILLANCE SYSTEM FOR COVID-19
SHORT RESEARCH COMMUNICATION | WOMEN’S HEALTH
SYSTEMATIC REVIEW
SYSTEMATIC REVIEW ARTICLE | UTI AND PULMONARY INJURY
WAME STATEMENT
View/Download PDF

Translate this page into:

REVIEW ARTICLE | HIV TESTING
2025
:14;
e016
doi:
10.25259/IJMA_4_2025

Effectiveness of Human Immunodeficiency Virus Index Testing: A Global Scoping Review

Department of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Independent Public Health Researcher, Raigarh, Chhattisgarh, India
Author image

*Corresponding author: Aditi Chandrakar, Department of Community and Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. E-mail: draditi7in7@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Galhotra A, Agrawal S, Chandrakar A. Effectiveness of human immunodeficiency virus index testing: A global scoping review. Int J Matern Child Health AIDS. 2025;14:e016. doi: 10.25259/IJMA_4_2025

Abstract

Background and Objective:

Over 2.5 million people are living with human immunodeficiency virus (HIV) in India. The World Health Organization recommends HIV self-screening and partner notification services. Index testing is a case-finding approach that focuses on eliciting the sexual or needle-sharing partners and biological children of HIV-positive individuals. This review aims to understand the effectiveness of index case testing in the uptake of HIV diagnosis and care.

Methods:

A scoping review was conducted to examine the effectiveness of HIV index case testing. Studies published between 2010 and 2024 in English were included. A total of 10 final studies were included in this scoping review. No such studies were found in the Indian context.

Results:

The studies were from Zimbabwe, Malawi, Nigeria, South Africa, Lesotho, Kenya, Zambia, Mozambique, and Ukraine. Sample sizes ranged from under 1,000 individuals to large-scale community-based programs enrolling over 38,000 participants. The studies demonstrated the effectiveness of index case testing in identifying previously undiagnosed HIV infections among sexual partners (up to 51%) and children (4.0–5.8%) of people living with HIV. The studies also indicated high acceptance rates and feasibility of the approach.

Conclusion and Global Health Implications:

HIV index case testing presents a valuable strategy for reaching diverse populations at risk for HIV infection and improving care linkages. Further research is needed to explore cost-effectiveness and optimize implementation strategies for various contexts.

Keywords

Contact Tracing
Human Immunodeficiency Virus
HIV Testing
Index Case Testing
Linkage to Care

INTRODUCTION

New human immunodeficiency virus (HIV) infections and acquired immunodeficiency syndrome (AIDS)-related deaths in India dropped by 44% (1.2 lakhs to 68,450) and 80% (1.6 lakhs to 35,870), respectively, between 2010 and 2023,[1] both outclassed the global average; however, 185 Indians were infected each day in 2023.[2] HIV prevention efforts need to be accelerated if India is to meet the sustainable development goal (SDG) 3.3 target of ending AIDS as a public health threat by 2030. To achieve SDG 3.3, early diagnosis of HIV and prompt linkage of the diagnosed case to anti-retroviral treatment (ART), along with prevention of new HIV infections, is the key.

In India, 81% of the people living with HIV (PLHIV) know their status, and 70% of PLHIV are on ART, implying that many with HIV were unaware of their status.[1] There is an increasing focus on HIV testing in high-risk or key groups such as people who inject drugs, men who have sex with men (MSM), and female sex workers. However, sexual partners of index-positive clients are an important population that has largely been ignored due to the reluctance to disclose information about their sexual partners, stigma, and social barriers. This high-risk group establishes a “pivotal point” that must be reached to achieve HIV control, thereby attaining the 1st 95% of the 95-95-95 initiative.[3]

The Government of India introduced newer strategies that reinforce these targets under the National AIDS Control Program (NACP-V). One of these strategies is HIV index testing, which the National AIDS Control Organization introduced in a campaign mode. The campaign was from April 15th, 2024, to October 15th, 2024, with pan-India implementation. The first phase was from April 15th, 2024, to July 15th, 2024, in all districts having ART centers; whereas the second phase, from July 15th, 2024, to October 15th, 2024, included the remaining districts.[4]

Index testing is an evidence-based, World Health Organization (WHO)-endorsed form of contact tracing. It involves identifying and testing partners as well as biological children who are at risk of vertical transmission of HIV. It is a targeted approach to identify undiagnosed infections and improve diagnosis rates.[5] Index testing focuses on individuals diagnosed with HIV, referred to as the “index case.”[6] These individuals are offered counseling to disclose their status to their sexual partners, children, and other close contacts.[7] Healthcare providers then work with the index case to encourage these contacts to undergo HIV testing. This strategy leverages existing connections and overcomes the stigma associated with routine testing.[8]

Early diagnosis allows PLHIV to initiate ART, which suppresses the virus and reduces the risk of transmission.[9] Late diagnosis of HIV is an important factor associated with HIV-related morbidity and mortality. Early HIV diagnosis has benefits on individual and population levels.[10] At an individual level, it significantly enhances quality of life by enabling timely access to ART, which prevents opportunistic infections, reduces transmission risk, and prolongs life expectancy. Knowing HIV status empowers individuals to make informed decisions about their health. At a population level, it significantly reduces new infections, strengthens healthcare systems, and stimulates economic growth.

This scoping review was carried out with the research question “How effective is Index case testing in the uptake of HIV testing and counselling services (HFS), diagnosing partners, and linking them to care?

METHODS

This scoping review adhered to PRISMA-ScR and Arksey and O’Malley’s guidelines.[11] A search for relevant studies was carried out in the database PubMed, and an additional search was done in Google Scholar. The search was first performed using MeSH terms. The terms “HIV,” “AIDS,” “index cases,” “HIV Care,” “linkage to care,” “HIV partner testing,” “HIV contact,” “global,” “HIV care continuum,” and “Index testing” were among those used [Table 1]. The WHO and US Centers for Disease Control and Prevention websites were also checked for information about the HIV and AIDS program and operating procedures. The Mendeley software was then used to import relevant records and eliminate duplicate documents. Following that, full-text papers were filtered per the eligibility criteria listed in Table 1. To acquire more data, cross-references were gathered from the appropriate papers.

Table 1: Inclusion and exclusion criteria for study selection.
Items Criteria
Database PubMed Central, Google Scholar
Time From the year 2010 to 2024
Spatial filter Worldwide
Language filter English
Inclusion criteria 1. Peer-reviewed published paper
2. Performed using policy analysis or original data
3. Study conducted for HIV index testing services or partner notification services.

HIV: Human immunodeficiency virus.

Search Results

A total of 396 records were initially identified through database searching. The 343 unique records were screened after removing 53 duplicates. The articles were assessed for inclusion criteria, and ultimately, 7 records were found relevant, and 3 articles were selected from back-referencing the included articles, resulting in 10 final studies [Figure 1].

Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart for inclusion of study articles.
Figure 1:
Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart for inclusion of study articles.

Characteristics of Reviewed Studies

The studies included participants from Zimbabwe, Malawi, Nigeria, South Africa, Lesotho, Kenya, Zambia, Mozambique, and Ukraine. Sample sizes ranged from under 1,000 individuals to large-scale community-based programs enrolling over 38,000 participants [Table 2]. A total of 10 studies were included, of which 50% of the studies were community-based, two studies were retrospective cross-sectional, and one study each had with retrospective cohort, mixed method, and intervention design.

Table 2: Characteristics of included studies (n=10).
S. No. Author Year Study design Country Sample size Study population Result Key findings
1. Kranzeret al. 2014 Mixed Method Zimbabwe 2,831 children Children
6–15 years
19.8% of the 940 guardians who tested with the youngster had HIV. PITC was offered to 76% of the 2,831 eligible children, and 54.2% of them agreed to be tested for HIV. Of those screened, 95% of children with HIV were connected to care.
2. Ahmedet al. 2017 Community- based Malawi 1567 patients HIV-infected children
(1–15 years) and young persons
(>15–24 years)
After testing
711 children and youth, CHWs identified 28 new HIV-positive individuals.
The index case-finding strategy is acceptable and workable and promotes prompt linkage to care when paired with home-based testing and monitored follow-up.
3. Katbi
et al.
2018 Non- controlled interventional Nigeria 1277 index clients PLHIV and their partners 51% of partners HIV positive Identified the need to reach sexual partners of PLHIV for testing and treatment.
4. Joseph Davey
et al.
2019 Community- based South Africa 16,033 partners and children PLHIV partners and children 38% HIV positive Index partner/child testing is feasible and effective for case finding.
5. Jubileeet al. 2019 Community- based Lesotho 7916 index clients PLHIV, their biological children and partners Higher HIV positivity rates and linkage rates were observed with HIV index testing compared to other models. Linkage to care and treatment was higher among those identified through HIV index testing.
6. Mugo
et al.
2020 Prospective cohort Kenya 493 caregivers with children Children of PLHIV 5.8% HIV prevalence Home-based testing is feasible, but uptake was moderate.
7. Kariukiet al. 2020 Retrospective cross- sectional Kenya 183 index clients PLHIV and their partners 216 sexual partners were evoked for tracing by 89% of the indexed clients who accepted the services. In low-resource nations, assisted partner notification programs are both acceptable and successful in boosting the identification of HIV cases among sexual partners who have been exposed.
8. Mwangoet al. 2020 Community- based Zambia 38,255 persons Men living with HIV Among those tested, 29% were newly identified as people living with HIV. Among men, 24% tested positive, with index testing yielding higher positivity but lower linkage compared to targeted community testing.
9. Songaneet al. 2023 Community- based Mozambique 91,411 individuals Parents of PLHIV, sexual partners, and biological children under the age of 14 7,011 people received a new HIV diagnosis because of community index testing. Extending the community index case technique could be an economical and successful way to find people who have never been diagnosed with HIV, especially men.
10. Secor
et al.
2024 Retrospective cross- sectional Ukraine 14,554 adults PLHIV adults Within 7 days of testing, named couples had a considerably higher chance of starting ART. By reducing the time between HIV testing and starting ART and bringing PLHIV into treatment earlier during their HIV disease, index testing services may help to improve patient outcomes and retention.

HIV: Human immunodeficiency virus, PLHIV: People living with human immunodeficiency virus, ART: Anti-retroviral treatment, PITC: Provider-initiated HIV testing and counseling.

RESULTS

Increased Case Identification

A finding across the studies was the effectiveness of index testing in identifying previously undiagnosed HIV infections. The studies documented a 51%[12] HIV positivity among partners of PLHIV, highlighting a risk for transmission within these close relationships. The studies found a prevalence of 4.0[13]–5.8%[14] among children of PLHIV, raising concerns about potential mother-to-child transmission during pregnancy, childbirth, or breastfeeding.

Feasibility, Acceptability, and Linkage to Care

The studies indicated that index testing is feasible and well-accepted by both the index client and their contacts. Studies observed good acceptance of index testing services by PLHIV clients, with a willingness to disclose their status and encourage partner testing.[15-17] Community-based approaches utilizing home-based testing and trained community health workers (CHWs) demonstrated successful outreach to geographically dispersed populations and those facing barriers to facility-based testing.[13,15,18] Studies reported higher rates of linkage to care and treatment initiation among those diagnosed through index testing compared to traditional methods.[14,15,19]

Effectiveness across Populations

The studies included diverse populations, demonstrating the potential of index testing to reach various groups at risk for HIV infection. Studies focusing on children of PLHIV identified a significant burden of undiagnosed infections, highlighting the importance of including children in index testing strategies.[13,14,20,21] One study involving adolescents and young people showed promise in reaching this age group with a high-yield case identification rate.[13] Studies targeting MSMs, often underdiagnosed due to social stigma, yielded positive results for case identification.[17]

Cost-effectiveness

Index testing emerged as a cost-effective approach for identifying new HIV cases in Mozambique.[18] While the initial cost of $65.32 per new HIV diagnosis, this figure decreased to $362 per infection averted within 5 years. This method proved more efficient than traditional facility-based testing, detecting a higher percentage of new HIV cases (7.7% compared to 4.1%). Community index testing was more successful in diagnosing HIV among males.[18]

While the studies provide strong evidence for the effectiveness of index testing, some challenges identified were:

  • The 5 Cs (consent, confidentiality, counseling, correct results, connection, or linkages) of HIV testing must be maintained in the context of index testing

  • Individual factors – self-stigma, i.e., key populations are usually reluctant to divulge their contacts and details about their family due to stigma

  • Interpersonal factors such as fear of divorce and separation

  • Health system factors such as gaps in training healthcare workers on effective communication and counseling skills, and a lack of confidential space for counseling

  • HIV-related stigma in the community.[22]

DISCUSSION

This review aligns with previous studies by the WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS), which emphasize the usefulness of index testing in recognizing hidden reservoirs of HIV within social networks.[23,24] The prevalence rates observed among partners and children in this review (51% for partners and 4.0–5.8% for children) are comparable to those reported in other studies (35–62% for partners and 4–18% for children).[25] This consistency strengthens the evidence base for the strategy’s ability to detect undiagnosed infections and contribute to achieving targets.

The studies found high acceptance rates for index testing among PLHIV clients, like Edosa et al.[6] and Kumar et al.[26] This suggests a willingness among PLHIV to participate in efforts to prevent onward transmission within their social circles. This review aligns with Mushamiri et al., demonstrating the effectiveness of community-based outreach strategies using CHWs to reach geographically dispersed populations.[27] The observed improvement in linkage to care among those diagnosed through index testing is also consistent with Oljira et al., who reported a higher rate of ART initiation among partners identified through this approach.[28] These findings suggest that index testing is not only feasible and acceptable but also holds promise for improving care cascades by facilitating earlier access to treatment.

The present review highlights the potential of index testing to reach diverse populations at risk for HIV infection, including children, adolescents, and MSM.[13,20] The inclusion of MSM populations in this review adds to the growing body of evidence suggesting the strategy’s utility in reaching groups often facing social stigma and barriers to healthcare access. This review identified challenges like those reported in previous studies, including the need for specialized training for healthcare workers on communication and counseling skills, particularly for addressing disclosure concerns.

Limitations

Since this is a scoping review, it provides a moderate level of evidence, and there always remains a risk of bias due to the heterogeneity of the studies.

CONCLUSION AND GLOBAL HEALTH IMPLICATIONS

Through the evidence presented by this scoping review, there is no doubt that index testing is a high-yielding strategy to fast-track the identification of new cases of HIV and to sustain the high levels of linkages to ART. It is specifically effective in increasing the detection and testing of biological children. This is a welcome and much-needed strategy to cater to the high-risk/key population where HIV remains focused, but to include it in NACP-V, the various limitations cited above need to be taken care of. Without targeted intervention offering HIV index testing services to key population clusters, including sexual partners, it will be a challenge to end HIV/AIDS by 2030.

Key Message

For the goal of ending HIV/AIDS by 2030, targeted HIV testing for key populations, including sexual partners of index PLHIV, is essential.

Acknowledgments:

None.

COMPLIANCE WITH ETHICAL STANDARDS

Conflicts of Interest: The authors declare no competing interests. Financial Disclosure: Nothing to declare. Funding/Support: There was no funding for this study. Ethics Approval: Not applicable. Declaration of Patient Consent: Patient’s consent is not required, as there are no patients in this study. Use of Artificial Intelligence (AI)-Assisted Technology for Manuscript Preparation: The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI. Disclaimer: None.

References

  1. . India HIV estimate 2023, technical report. . [cited 2025 Apr 14]. Available from: https://naco.gov.in
    [Google Scholar]
  2. . Indian effort needed to end AIDS as a global public health threat by 2030: UNAIDS. The Hindu 2024 [cited 2024 Oct 9]. Available from: https://www.thehindu.com/sci-tech/health/indian-effort-needed-to-end-aids-as-a-global-public-health-threat-by-2030-unaids/article68713804.ece
    [Google Scholar]
  3. . [cited 2024 Oct 9]. Available from: https://www.unaids.org/en/resources/fact-sheet
  4. . MoHFW-GoI. [cited 2024 Jul 23]. Available from: https://naco.gov.in/national-aids-control-programme-v
    [Google Scholar]
  5. , , , , , , et al. Family testing: an index case finding strategy to close the gaps in pediatric hiv diagnosis. J Acquir Immune Defic Syndr. 2018;78(Suppl 2):S88-97.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , . Acceptance of index case HIV testing and its associated factors among HIV/AIDS clients on ART follow-up in west Ethiopia: A Multi-Centered Facility-Based Cross-Sectional Study. HIV AIDS (Auckl). 2022;14:451-60.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , . HIV Positive status disclosure to sexual partners: a qualitative study to explore experiences and challenges among clients attending HIV care services in NorthWestern Tanzania. AIDS Care. 2023;35(7):953-60.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Improving HIV case finding through index testing: findings from health facilities in 12 districts of South Africa, October 2019-September 2021. AIDS Behav. 2024;28(5):1708-18.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , , , et al. The detection and management of early hiv infection: a clinical and public health emergency. J Acquir Immune Defic Syndr. 2013;63(Suppl 2):S187-99.
    [CrossRef] [PubMed] [Google Scholar]
  10. , . Recent HIV infection: diagnosis and public health implications. diagnostics (Basel). 2022;12(11):2657.
    [CrossRef] [PubMed] [Google Scholar]
  11. , . Scoping Studies: Towards a Methodological Framework. Int J Soc Res Methodol. 2005;8:19-32.
    [CrossRef] [Google Scholar]
  12. , , , , , , et al. Effect of clients strategic index case testing on community-based detection of HIV infections (STRICT Study) Int J Infect Dis. 2018;74:54-60.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. Index case finding facilitates identification and linkage to care of children and young persons living with HIV/AIDS in Malawi. Trop Med Int Health. 2017;22(8):1021-9.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Home-and clinic-based pediatric hiv index case testing in Kenya: Uptake, HIV Prevalence, Linkage to Care, and Missed Opportunities. JAIDS J Acquir Immune Defic Syndr. 2020;85(5):535-42.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , . HIV index testing to improve HIV positivity rate and linkage to care and treatment of sexual partners, adolescents and children of PLHIV in Lesotho. PLoS One. 2019;14(3):e0212762.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , . What is the level of uptake of partner notification services in hiv testing in selected health facilities in Gatanga Sub County, Muranga County-Kenya; a retrospective study. BMC Infect Dis. 2020;20(1):432.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Index and targeted community-based testing to optimize HIV case finding and ART linkage among men in Zambia. J Int AIDS Soc. 2020;23(Suppl 2):e25520.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. HIV community index testing reaches proportionally more males than facility-based testing and is cost-effective: a study from Gaza Province, Mozambique. PLoS One. 2023;18(5):e0286458.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , , , et al. Does HIV index testing bring patients into treatment at earlier stages of HIV Disease? results from a retrospective study in Ukraine. BMC Infect Dis. 2024;24(1):328.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. Barriers to provider-initiated testing and counselling for children in a High HIV prevalence setting: a mixed methods study. PLoS Med. 2014;11(5):e1001649.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , , , et al. HIV positivity and referral to treatment following testing of partners and children of PLHIV index patients in public sector facilities in South Africa. J Acquir Immune Defic Syndr. 2019;81(4):365-70.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , , , et al. Implementation process and challenges of index testing in Côte D'ivoire from healthcare workers' perspectives. PLoS One. 2023;18(2):e0280623.
    [CrossRef] [PubMed] [Google Scholar]
  23. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. [cited 2024 Jul 14]. Available from: https://www.who.int/publications/i/item/9789240031593
    [Google Scholar]
  24. 2021 UNAIDS Global AIDS Update - confronting inequalities - lessons for pandemic responses from 40 years of AIDS. [cited 2024 Jul 14]. Available from: https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update
    [Google Scholar]
  25. , , , , , , et al. Outcome of HIV testing among family members of index cases across 36 facilities in Abidjan, Côte D'ivoire. AIDS Behav. 2021;25(2):554-61.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , . Factors affecting disclosure of hiv-positive serostatus among people living with HIV/AIDS attending an antiretroviral therapy center of eastern India. Indian J Public Health. 2020;64(1):4-10.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , , . Evidence on the effectiveness of community-based primary health care in improving HIV/AIDS outcomes for mothers and children in low-and middle-income countries: findings from a systematic review. J Glob Health. 2021;11:11001.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , . Partner notification service utilization and associated factors among clients attending anti-retroviral therapy clinics of public health facilities in Gimbi Town, West Ethiopia, 2023: A Facility-Based Mixed-Method Cross-Sectional Study. BMC Public Health. 2024;24(1):687.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections